DDPO is an inhibitor for dihydrofolate reductase (DHFR) with an IC 50 of 0.035 µM. DDPO inhibits the cell growth of cancer cell L1210 and WI-L2with IC 50 of 5 and 0.28 µM.
Products | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Dihydrofolate reductase (DHFR)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.